HT
JNCE

HAP Trading’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

HAP Trading’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,900
Closed -$15K – 2949
2021
Q4 		$15K Buy
+11,900
New +$98K ﹤0.01% 1936
2021
Q1 		– Sell
-11,000
Closed -$16K – 2704
2020
Q4 		$16K Buy
+11,000
New +$85.6K ﹤0.01% 1790
2020
Q3 		– Sell
-16,600
Closed -$7K – 2006
2020
Q2 		$7K Buy
+16,600
New +$89.5K ﹤0.01% 1515

Other funds holding JNCE

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return